Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 452

1.

Hypertension and chronic kidney disease is highly prevalent in elderly patients with colorectal cancer undergoing primary surgery.

Kozłowski L, Kozłowska K, Małyszko J.

Adv Clin Exp Med. 2019 Aug 30. doi: 10.17219/acem/104537. [Epub ahead of print]

PMID:
31469951
2.

Summary of the International Conference on Onco-Nephrology: an emerging field in medicine.

Capasso A, Benigni A, Capitanio U, Danesh FR, Di Marzo V, Gesualdo L, Grandaliano G, Jaimes EA, Malyszko J, Perazella MA, Qian Q, Ronco P, Rosner MH, Trepiccione F, Viggiano D, Zoccali C, Capasso G; International Conference on Onco-Nephrology Participants.

Kidney Int. 2019 Sep;96(3):555-567. doi: 10.1016/j.kint.2019.04.043. Epub 2019 May 31.

PMID:
31445584
3.

Toxic epidermal necrolysis (Lyell syndrome) as a severe and fatal manifestation of multiple myeloma with amyloidosis in patient with rapidly developing end-stage kidney disease.

Kępska-Dzilińska M, Kohmann A, Kuriga M, Puła B, Matuszkiewicz-Rowińska J, Małyszko J.

Pol Arch Intern Med. 2019 Aug 16. doi: 10.20452/pamw.14932. [Epub ahead of print] No abstract available.

4.

Erratum to: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Aug 9. pii: gfz137. doi: 10.1093/ndt/gfz137. [Epub ahead of print] No abstract available.

PMID:
31397476
5.

State of the art - sirtuin 1 in kidney pathology - clinical relevance.

Bazyluk A, Malyszko J, Hryszko T, Zbroch E.

Adv Med Sci. 2019 May 21;64(2):356-364. doi: 10.1016/j.advms.2019.04.005. [Epub ahead of print] Review.

PMID:
31125865
6.

Urinary and Serum Biomarkers for Prediction of Acute Kidney Injury in Patients Undergoing Liver Transplantation.

Lewandowska L, Małyszko J, Joanna Matuszkiewicz-Rowińska J.

Ann Transplant. 2019 May 21;24:291-297. doi: 10.12659/AOT.914975.

7.

Mild cognitive impairment and kidney disease: clinical aspects.

Viggiano D, Wagner CA, Blankestijn PJ, Bruchfeld A, Fliser D, Fouque D, Frische S, Gesualdo L, Gutiérrez E, Goumenos D, Hoorn EJ, Eckardt KU, Knauß S, König M, Malyszko J, Massy Z, Nitsch D, Pesce F, Rychlík I, Soler MJ, Spasovski G, Stevens KI, Trepiccione F, Wanner C, Wiecek A, Zoccali C, Unwin R, Capasso G.

Nephrol Dial Transplant. 2019 Apr 9. pii: gfz051. doi: 10.1093/ndt/gfz051. [Epub ahead of print] No abstract available.

PMID:
31071220
8.

Problems of nephrooncology. Proceedings from the 1st Scientific and Training Conference Nephrooncology 5-6 October 2018, Gdańsk, Poland.

Bączkowska T, Bissler JJ, Błasińska‑Przerwa K, Borawski J, Chudek J, Ciechanowski K, Czarkowska‑Pączek B, Dębska-Ślizień A, Domański M, Durlik M, Gellert R, Gozdowska J, Goździk M, Imko‑Walczuk B, Janiszewski J, Januszko‑Giergielewicz B, Jeśkiewicz M, Jóźwiak S, Kadylak D, Klinger M, Kosieradzki M, Kotulska K, Kozak Ł, Król E, Krzanowska K, Kurnatowska I, Labij‑Reduta B, Lichodziejewska‑Niemierko M, Lizakowski S, Małyszko J, Matuszewski M, Mazurkiewicz J, Mełeń‑Mucha G, Myślak M, Naumnik B, Nowicki M, Oko A, Pączek L, Perkowska-Ptasińska A, Piątak M, Piecha G, Radzikowska E, Renke M, Rutkowska B, Sawosz M, Skutecki R, Słowińska M, Sosińska‑Mielcarek K, Szafran‑Dobrowolska J, Szołkowska M, Szczepulska‑Wójcik E, Szurowska E, Tarasewicz A, Wągrowska‑Danilewicz M, Wołowiec D, Woźniak J, Zawiasa‑Bryszewska A.

Pol Arch Intern Med. 2019 May 2;129(Spec. Issue 2):1-74. doi: 10.20452/pamw.14821. Epub 2019 May 2. No abstract available.

9.

Do we know more about hypertension in Poland after the May Measurement Month 2017?-Europe.

Małyszko J, Mastej M, Banach M, Tykarski A, Narkiewicz K, Hoffman P, Jankowski P, Nowicki MP, Tomasik T, Windak A, Olszanecka A, Motyl A, Nowak D, Skowron Ł, Tomaszewski M, Beaney T, Xia X, Nillson P, Poulter NR, Jóźwiak J.

Eur Heart J Suppl. 2019 Apr;21(Suppl D):D97-D100. doi: 10.1093/eurheartj/suz067. Epub 2019 Apr 24.

10.

Peritoneal Ultrafiltration in the Long-Term Treatment of Chronic Heart Failure Refractory to Pharmacological Therapy.

Wojtaszek E, Grzejszczak A, Niemczyk S, Malyszko J, Matuszkiewicz-Rowińska J.

Front Physiol. 2019 Mar 28;10:310. doi: 10.3389/fphys.2019.00310. eCollection 2019.

11.

A chance to live to a ripe old age with a transplanted kidney.

Wojtaszek E, Małyszko J, Grzejszczak A, Matuszkiewicz-Rowińska J, Maciąg R, Rowiński O.

Pol Arch Intern Med. 2019 Aug 29;129(7-8):551-553. doi: 10.20452/pamw.14770. Epub 2019 Mar 29. No abstract available.

12.

Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease.

Malyszko J, Malyszko JS, Matuszkiewicz-Rowinska J.

Expert Opin Ther Targets. 2019 May;23(5):407-421. doi: 10.1080/14728222.2019.1599358. Epub 2019 Apr 1.

PMID:
30907175
13.

Jakub Chlebowski, Rector Magnificus Exultus - A Distinguished Professor of Internal Medicine in Postwar North-East Poland.

Wincewicz A, Woltanowski P, Sulkowski S, Małyszko J.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2018 Dec 1;39(2-3):143-154. doi: 10.2478/prilozi-2018-0054.

PMID:
30864358
14.

Erratum.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Feb 28. pii: gfz047. doi: 10.1093/ndt/gfz047. [Epub ahead of print] No abstract available.

PMID:
30820538
15.

Hepcidin - Potential biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions.

Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Koc-Zorawska E, Matuszkiewicz-Rowinska J, Dobrzycki S.

Adv Med Sci. 2019 Feb 25;64(2):211-215. doi: 10.1016/j.advms.2018.12.008. [Epub ahead of print]

PMID:
30818219
16.

Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study-A Comparison.

Zawierucha J, Malyszko J, Malyszko JS, Prystacki T, Marcinkowski WP, Dryl-Rydzynska T.

Front Endocrinol (Lausanne). 2019 Feb 5;10:40. doi: 10.3389/fendo.2019.00040. eCollection 2019.

17.

Selected Legal Aspects of Donation After Circulatory Death in Poland.

Guzik-Makaruk EM, Olesiuk-Okomska M, Matuszkiewicz-Rowińska J, Małyszko J.

Ann Transplant. 2019 Feb 18;24:93-99. doi: 10.12659/AOT.912567. Review.

18.

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Feb 1;34(2):208-230. doi: 10.1093/ndt/gfy407.

PMID:
30753708
19.

Vitamin D deficiency and anemia is highly prevalent and dependent on the etiology of heart failure: A pilot study.

Małyszko J, Tomaszuk-Kazberuk A, Dobrzycki K, Bachórzewska-Gajewska H, Zorawski M, Koc-Zorawska E, Kobus G, Dobrzycki S.

Cardiol J. 2019 Jan 30. doi: 10.5603/CJ.a2019.0003. [Epub ahead of print]

20.

Urgent-Start Peritoneal Dialysis as a Bridge to Definitive Chronic Renal Replacement Therapy: Short- and Long-Term Outcomes.

Wojtaszek E, Grzejszczak A, Grygiel K, Małyszko J, Matuszkiewicz-Rowińska J.

Front Physiol. 2019 Jan 4;9:1830. doi: 10.3389/fphys.2018.01830. eCollection 2018.

21.

Heart failure and mid-range ejection fraction and its relation to acute kidney injury and chronic kidney disease.

Małyszko J, Matuszkiewicz-Rowińska J.

Pol Arch Intern Med. 2018 Dec 21;128(12):716-718. doi: 10.20452/pamw.4401. Epub 2018 Dec 21. No abstract available.

22.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y.

PMID:
30538326
23.

Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery - a 867 Patient Study.

Tomaszuk-Kazberuk A, Nikas D, Lopatowska P, Młodawska E, Malyszko J, Bachorzewska-Gajewska H, Dobrzycki S, Sobkowicz B, Goudevenos I.

Kidney Blood Press Res. 2018;43(6):1796-1805. doi: 10.1159/000495637. Epub 2018 Nov 30.

24.

Hypertension prevalence in early breast cancer patients undergoing primary surgery.

Kozłowska K, Kozłowski L, Małyszko J.

Adv Med Sci. 2019 Mar;64(1):32-36. doi: 10.1016/j.advms.2018.10.003. Epub 2018 Nov 9.

PMID:
30419489
25.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30361677
26.

Kallistatin Concentration and Hypertension in Heart Transplant Recipients.

Przybyłowski P, Wasilewski G, Koc-Żórawska E, Małyszko J.

Transplant Proc. 2018 Sep;50(7):2105-2109. doi: 10.1016/j.transproceed.2018.02.167. Epub 2018 Mar 13.

PMID:
30177118
27.

Vitamin D Concentration in Patients After Heart and Kidney Transplantation.

Przybyłowski P, Wasilewski G, Koc-Żórawska E, Małyszko J.

Transplant Proc. 2018 Sep;50(7):2100-2104. doi: 10.1016/j.transproceed.2018.02.171. Epub 2018 Mar 13.

PMID:
30177117
28.

Future Lawyers Support Organ Donation and Transplantation.

Rydzewska M, Drobek NA, Małyszko ME, Zajkowska A, Guzik-Makaruk EM, Pływaczewski EW, Malyszko J.

Transplant Proc. 2018 Sep;50(7):1946-1952. doi: 10.1016/j.transproceed.2018.03.131. Epub 2018 Mar 30.

PMID:
30177085
29.

Opinions and Attitudes of Medical Students About Organ Donation and Transplantation.

Rydzewska M, Drobek NA, Małyszko ME, Zajkowska A, Malyszko J.

Transplant Proc. 2018 Sep;50(7):1939-1945. doi: 10.1016/j.transproceed.2018.03.128. Epub 2018 Mar 28.

PMID:
30177084
30.

The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance.

Batko K, Malyszko J, Jurczyszyn A, Vesole DH, Gertz MA, Leleu X, Suska A, Krzanowski M, Sułowicz W, Malyszko JS, Krzanowska K.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1440-1452. doi: 10.1093/ndt/gfy259.

PMID:
30169860
31.

Progression to chronic kidney disease in patients undergoing nephrectomy for small renal masses: a price to pay for a therapeutic success?

Charytoniuk T, Małyszko M, Bączek J, Fiedorczuk P, Siedlaczek K, Małyszko J.

Postgrad Med. 2018 Sep;130(7):613-620. doi: 10.1080/00325481.2018.1511211. Epub 2018 Aug 27. Review.

PMID:
30106608
32.

The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council.

Zoccali C, Arici M, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Malyszko J, Massy Z, Rychlík I, Spasovski G.

Clin Kidney J. 2018 Aug;11(4):437-442. doi: 10.1093/ckj/sfy064. Epub 2018 Jul 31.

33.

Takotsubo syndrome and chronic kidney disease: a deadly duet in long-term follow-up.

Zalewska-Adamiec M, Małyszko J, Bachórzewska-Gajewska H, Tomaszuk-Kazberuk A, Kożuch M, Kralisz P, Dobrzycki S.

Pol Arch Intern Med. 2018 Sep 28;128(9):518-523. doi: 10.20452/pamw.4309. Epub 2018 Jul 27.

34.

Endocan Concentration in Kidney Transplant Recipients.

Malyszko J, Koc-Żórawska E, Malyszko JS.

Transplant Proc. 2018 Jul - Aug;50(6):1798-1801. doi: 10.1016/j.transproceed.2018.02.123. Epub 2018 Mar 14.

PMID:
30056903
35.

Underrecognition and Underestimation of Disturbances in Calcium-Phosphate Balance in Kidney Transplant Recipients.

Malyszko J, Koc-Zorawska E, Kozminski P, Matuszkiewicz-Rowinska J, Malyszko JS.

Transplant Proc. 2018 Jul - Aug;50(6):1790-1793. doi: 10.1016/j.transproceed.2018.02.155. Epub 2018 Mar 14.

PMID:
30056901
36.

Eye Problems in Patients on the Active and Inactive Kidney Transplantation Waiting List.

Krasnicki P, Malyszko J, Małyszko JS.

Transplant Proc. 2018 Jul - Aug;50(6):1634-1636. doi: 10.1016/j.transproceed.2018.02.139. Epub 2018 Mar 14.

PMID:
30056873
37.

Comorbidities on kidney transplantation waiting list relative to the status of the potential recipient.

Malyszko J, Dryl-Rydzynska T, Marcinkowski W, Prystacki T, Malyszko JS.

Arch Med Sci. 2018 Jun;14(4):941-944. doi: 10.5114/aoms.2016.60337. Epub 2016 Jun 1. No abstract available.

38.

Cardiovascular Outcomes Reported in Hemodialysis Trials.

O'Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Roy D, Herrington WG, Herzog CA, Jafar T, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AYM, Wanner C, Zannad F, Winkelmayer WC, Webster AC, Wheeler DC.

J Am Coll Cardiol. 2018 Jun 19;71(24):2802-2810. doi: 10.1016/j.jacc.2018.04.012. Review.

39.

The prevalence of hepatitis C and B among patients on hemodialysis and on renal transplantation waiting list in Poland has significantly decreased during the last 10 years.

Malyszko J, Zawierucha J, Marcinkowski W, Prystacki T, Dryl-Rydzynska T, Malyszko JS, Matuszkiewicz-Rowinska J.

Int Urol Nephrol. 2018 Aug;50(8):1555-1556. doi: 10.1007/s11255-018-1897-7. Epub 2018 Jun 4. No abstract available.

40.

Cardiovascular risk in chronic kidney disease: what is new in the pathogenesis and treatment?

Bazyluk A, Malyszko J, Zbroch E.

Postgrad Med. 2018 Jun;130(5):461-469. doi: 10.1080/00325481.2018.1481714. Epub 2018 Jun 12. Review.

PMID:
29846140
41.

ERA-EDTA invests in transformation to greener health care.

Blankestijn PJ, Arici M, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Malyszko J, Massy Z, Rychlík I, Spasovski G, Zoccali C.

Nephrol Dial Transplant. 2018 Jun 1;33(6):901-903. doi: 10.1093/ndt/gfy092. No abstract available.

PMID:
29800317
42.

The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council.

Zoccali C, Arici M, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Malyszko J, Massy Z, Rychlík I, Spasovski G.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1077-1082. doi: 10.1093/ndt/gfy173.

PMID:
29796635
43.

Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?

Mlodawska E, Lopatowska P, Malyszko J, Banach M, Sobkowicz B, Covic A, Tomaszuk-Kazberuk A.

Int Urol Nephrol. 2018 Sep;50(9):1633-1642. doi: 10.1007/s11255-018-1877-y. Epub 2018 May 21. Review.

PMID:
29785661
44.

Hypertension in malignancy-an underappreciated problem.

Małyszko J, Małyszko M, Kozlowski L, Kozlowska K, Małyszko J.

Oncotarget. 2018 Apr 17;9(29):20855-20871. doi: 10.18632/oncotarget.25024. eCollection 2018 Apr 17. Review.

45.

Endothelium, asymmetric dimethylarginine, and atherosclerosis in chronic kidney disease.

Małyszko J, Matuszkiewicz-Rowińska J.

Pol Arch Intern Med. 2018 Mar 29;128(3):145-147. doi: 10.20452/pamw.4232. Epub 2018 Mar 29. No abstract available.

46.

Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients.

Malyszko J, Anker SD.

Clin Kidney J. 2017 Dec;10(Suppl 1):i25-i31. doi: 10.1093/ckj/sfx070. Epub 2017 Nov 28. Review.

47.

Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal.

Burlacu A, Genovesi S, Goldsmith D, Rossignol P, Ortiz A, Kalra PA, Małyszko J, Banach M, Kanbay M, Covic A.

Pharmacol Res. 2018 Mar;129:535-543. doi: 10.1016/j.phrs.2017.12.004. Epub 2017 Dec 5. Review.

PMID:
29208494
48.

Adhering to the principles of clinical pharmacology - the correct fixed combinations of antihypertensive drugs.

Lopatowska P, Mlodawska E, Tomaszuk-Kazberuk A, Banach M, Malyszko J.

Expert Rev Clin Pharmacol. 2018 Feb;11(2):165-170. doi: 10.1080/17512433.2018.1412826. Epub 2017 Dec 6. Review.

PMID:
29192802
49.

Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease.

Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J.

Int Urol Nephrol. 2018 Jan;50(1):121-125. doi: 10.1007/s11255-017-1741-5. Epub 2017 Nov 13.

50.

Telomere attrition, kidney function, and prevalent chronic kidney disease in the United States.

Mazidi M, Rezaie P, Covic A, Malyszko J, Rysz J, Kengne AP, Banach M.

Oncotarget. 2017 Sep 8;8(46):80175-80181. doi: 10.18632/oncotarget.20706. eCollection 2017 Oct 6.

Supplemental Content

Loading ...
Support Center